These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 23530060)
1. Farnesoid X receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytes. Caron S; Huaman Samanez C; Dehondt H; Ploton M; Briand O; Lien F; Dorchies E; Dumont J; Postic C; Cariou B; Lefebvre P; Staels B Mol Cell Biol; 2013 Jun; 33(11):2202-11. PubMed ID: 23530060 [TBL] [Abstract][Full Text] [Related]
2. Regulation of rat hepatic L-pyruvate kinase promoter composition and activity by glucose, n-3 polyunsaturated fatty acids, and peroxisome proliferator-activated receptor-alpha agonist. Xu J; Christian B; Jump DB J Biol Chem; 2006 Jul; 281(27):18351-62. PubMed ID: 16644726 [TBL] [Abstract][Full Text] [Related]
3. Identification of HNF-4α as a key transcription factor to promote ChREBP expression in response to glucose. Meng J; Feng M; Dong W; Zhu Y; Li Y; Zhang P; Wu L; Li M; Lu Y; Chen H; Liu X; Lu Y; Sun H; Tong X Sci Rep; 2016 Mar; 6():23944. PubMed ID: 27029511 [TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 inhibits hepatic lipogenesis via repression of carbohydrate response element binding protein and hepatocyte nuclear factor 4α. Hanse EA; Mashek DG; Becker JR; Solmonson AD; Mullany LK; Mashek MT; Towle HC; Chau AT; Albrecht JH Cell Cycle; 2012 Jul; 11(14):2681-90. PubMed ID: 22751438 [TBL] [Abstract][Full Text] [Related]
5. cAMP opposes the glucose-mediated induction of the L-PK gene by preventing the recruitment of a complex containing ChREBP, HNF4alpha, and CBP. Burke SJ; Collier JJ; Scott DK FASEB J; 2009 Sep; 23(9):2855-65. PubMed ID: 19406844 [TBL] [Abstract][Full Text] [Related]
6. Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. Bricambert J; Miranda J; Benhamed F; Girard J; Postic C; Dentin R J Clin Invest; 2010 Dec; 120(12):4316-31. PubMed ID: 21084751 [TBL] [Abstract][Full Text] [Related]
7. ChREBP downregulates SNAT2 amino acid transporter expression through interactions with SMRT in response to a high-carbohydrate diet. Velázquez-Villegas L; Noriega LG; López-Barradas AM; Tobon-Cornejo S; Méndez-García AL; Tovar AR; Torres N; Ortiz-Ortega VM Am J Physiol Endocrinol Metab; 2021 Jan; 320(1):E102-E112. PubMed ID: 33225719 [TBL] [Abstract][Full Text] [Related]
11. Mlx is the functional heteromeric partner of the carbohydrate response element-binding protein in glucose regulation of lipogenic enzyme genes. Stoeckman AK; Ma L; Towle HC J Biol Chem; 2004 Apr; 279(15):15662-9. PubMed ID: 14742444 [TBL] [Abstract][Full Text] [Related]
12. Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation. Dentin R; Benhamed F; Pégorier JP; Foufelle F; Viollet B; Vaulont S; Girard J; Postic C J Clin Invest; 2005 Oct; 115(10):2843-54. PubMed ID: 16184193 [TBL] [Abstract][Full Text] [Related]
14. HNF4α is required for Tkfc promoter activation by ChREBP. Tsukamoto R; Watanabe K; Kodaka M; Iwase M; Sakiyama H; Inoue Y; Suzuki T; Yamamoto Y; Shimizu M; Sato R; Inoue J Biosci Biotechnol Biochem; 2024 Jul; 88(8):941-947. PubMed ID: 38782732 [TBL] [Abstract][Full Text] [Related]
15. Hepatocyte nuclear factor 4 alpha and farnesoid X receptor co-regulates gene transcription in mouse livers on a genome-wide scale. Thomas AM; Hart SN; Li G; Lu H; Fang Y; Fang J; Zhong XB; Guo GL Pharm Res; 2013 Sep; 30(9):2188-98. PubMed ID: 23462932 [TBL] [Abstract][Full Text] [Related]
16. Krüppel-like factor-10 is directly regulated by carbohydrate response element-binding protein in rat primary hepatocytes. Iizuka K; Takeda J; Horikawa Y Biochem Biophys Res Commun; 2011 Sep; 412(4):638-43. PubMed ID: 21856285 [TBL] [Abstract][Full Text] [Related]
17. c-Myc is required for the CHREBP-dependent activation of glucose-responsive genes. Zhang P; Metukuri MR; Bindom SM; Prochownik EV; O'Doherty RM; Scott DK Mol Endocrinol; 2010 Jun; 24(6):1274-86. PubMed ID: 20382893 [TBL] [Abstract][Full Text] [Related]